Question 4: Specify the disease / study for which non-cellular therapy was given

Indicate if the individual is participating in the BMT CTN 17-02 study or receiving non-cellular therapy as treatment for MDS, multiple myeloma, myelofibrosis, sickle cell disease, or another disease. If the research participant is enrolled in a study or receiving therapy for a disease that is not captured in any of the above categories, specify in question 5

Question 5: Specify other disease / study

If you have indicated in question 4 ‘other disease/study’ please enter the disease or study patient has or will be given therapy for.

Question 6: Enrollment date (date of consent)

Report the date of consent for enrollment on non-cellular therapy protocol. Continue with the signature section of the form.

Signature Lines:

The FormsNet3SM application will automatically populate the signature data fields, including name and email address of person completing the form and date upon submission of the form.

Last modified: Nov 01, 2021